Discovery Life Sciences, a biosample and biomarker specialist, announced the appointment of Greg Herrema as Chief Executive Officer. With over 20 years of experience in the life sciences and industrial sectors, Mr. Herrema will lead Discovery’s next phase of expansion. He succeeds Glenn Bilawsky, who announced his intention to step down after leading Discovery’s transformation into a global provider of biospecimen products and multi-omics laboratory services.
Mr. Herrema joins Discovery after a successful career at Thermo Fisher Scientific, where he served as Senior Vice President and President of the global life sciences company’s laboratory supplies distribution business, including turnover exceeds 8 billion dollars. Previously, he led the Biosciences, Analytical Instruments, Scientific Instruments and Environmental Instruments sectors. Mr. Herrema began his career at General Electric. He serves on several boards of nonprofit organizations focused on land conservation and community engagement.
Glenn Bilawsky, who will remain on Discovery’s board of directors, said:
“Greg’s leadership skills, industry knowledge and commitment to social responsibility make him the ideal candidate to lead Discovery into its next phase of innovation and growth. I am confident in his ability to guide the company to new heights in our mission to restore hope by accelerating the development of innovative diagnostics and effective treatments to improve care. »
Under Mr. Bilawsky’s leadership, Discovery acquired 13 companies and launched internal initiatives that significantly expanded its scientific capabilities and services. The company recently opened its new global headquarters in a state-of-the-art facility housing biospecimen products and multi-omics analysis and biomarker services on the HudsonAlpha Biotechnology Institute campus in Huntsville . Today, Discovery supports more than 750 pharmaceutical, biotechnology and diagnostic companies with their research and development needs.
SOURCE : PRNewswire